ÁÖÁ¦º°°Ë»ö
(current)
Å°¿öµå°Ë»ö
(±¸)µ¥ÀÌÅÍ°Ë»ö
¾÷µ¥ÀÌÆ®Á¤º¸
°ü·Ã»çÀÌÆ®
À§¾ÏȯÀÚ¿¡¼ ±ÙÄ¡Àû À§ÀýÁ¦¼úÈÄ ½ÃÇàÇÑ º¸Á¶Àû PMF Ç×¾Ï ÈÇпä¹ý¿¡ ´ëÇÑ ¹«ÀÛÀ§ ÀüÇâÀû ¿¬±¸
Randomized Clinical Trial of Adjuvant Chemotherapy with Mitomycin, Cisplatin and 5-FU in Patients with Curative Resected Gastric Cancer
°í½Å´ëÇб³ ÀÇ°ú´ëÇÐ ÇмúÁö
2007³â 22±Ç 2È£ p.105 ~ p.110
ÃÖ¿ì½Ä
(Choi Woo-Sik) - °í½Å´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
½Å¿¬¸í
(Shin Yeon-Myeong) - °í½Å´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
ÃÖ°æÇö
(Choi Kyung-Hyun) - °í½Å´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
Abstract
Å°¿öµå
À§¾Ï ¼ö¼ú, PMF, º¸Á¶Ç×¾Ï Ä¡·á
KMID :
0857020070220020105
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
ÇÐȸ
µîÀçÀú³Î Á¤º¸
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
This study finded significant survival for stage IIIa gastric cancer with adjuvant PMF achemotherapy than oral 5-FU administration only.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°º¸ÇèÄÚµå